OPTIMIZATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS OF LEMONGRASS (CYMBOPOGON CITRATUS) ESSENTIAL OIL by Ujilestari, Tri et al.
 
 
OPTIMIZATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS OF LEMONGRASS 
(CYMBOPOGON CITRATUS) ESSENTIAL OIL 
Original Article 
 
TRI UJILESTARI1, BAMBANG ARIYADI2, RONNY MARTIEN3, ZUPRIZAL1, NANUNG DANAR DONO1* 
1Department of Animal Nutrition and Feed Science, Faculty of Animal Science, Universitas Gadjah Mada, Yogyakarta, Indonesia, 
2Department of Animal Production, Faculty of Animal Science, Universitas Gadjah Mada, Yogyakarta, Indonesia, 3
Received: 03 Oct 2018, Revised and Accepted: 19 Nov 2018 
Department of 
Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia 
Email: nanungdd@ugm.ac.id  
ABSTRACT 
Objective: Focus of this study was to optimize and to characterize the self-Nano emulsifying drug delivery system using lemongrass (Cymbopogon 
citratus) essential oil. 
Methods: The optimum formulas were analyzed using a D-Optimal mixture experimental design and performed using a Design Expert® Ver. 7.1.5. 
Formulation variables which include in the design were: oil component X1 (a mixture of Cymbopogon citratus essential oil and virgin coconut oil/VCO), 
surfactant X2 (Tween 80), and co-surfactant (PEG 400), while emulsification time in a sec (Y1) and transmittance in percent (Y2
Results: The optimum formula for SNEDDS in the current study were: Cymbopogon citratus essential oil (7.147%), VCO (7.147%), Tween 80 
(71.417%), and PEG 400 (14.290%). From the optimizing formula can be shown that the mean of droplet size, polydispersity-index, zeta potential, 
and viscosity were: 13.17±0.06 nm, 0.17±0.05,-20.90±1.47 mV, 200±0mPa
) as responses.  
. 
Conclusion: The optimized SNEDDS formula was improving solubility of poorly soluble Cymbopogon citratus essential oil. 
s (n=3), respectively. Furthermore, the optimized formula has passed the 
thermodynamic stability test; meanwhile, transmission electron microscopy displayed spherical shape. 
Keywords: Cymbopogon citratus, D-optimal mixture design, optimization, self-nanoemulsifying drug delivery system (SNEDDS) 




The productivity of broiler chickens can be optimal when the health 
condition of the gastrointestinal tract is in good condition [1]. The 
balanced population between pathogenic and beneficial microflora 
in the gastrointestinal tract plays an important role in nutrient 
digestion and absorption [2-4]. Escherichia coli, Salmonella 
typhimurium, and Clostridium perfringens are the three major 
pathogens in the gut of poultry [5]. Since the high public concerns on 
antibiotic resistance, the use of antibiotics as growth promoters in 
the diets of poultry has been banned. There is an urgent need to 
explore the alternative for antibiotic growth promoters [6]. 
Essential oils are potential alternatives for an in-feed antibiotic as they 
have antibacterial properties [7]. Essential oils are classified as 
phytobiotics that have pharmacological effects [8]. As shown in 
lemongrass (Cymbopogon citratus) essential oils, this phytobiotic have 
been found to be effective in inhibiting pathogenic bacteria, such as: 
Salmonella typhimurium [9], S. enterica [10], Escherichia coli, 
Staphylococcus aureus, Listeria monocytogenes [11], Klebsiella pneumonia 
[12, 13], and also antifungal activity against Candida albicans [14]. 
Essential oils are volatile substances, liquid, soluble in lipid and organic 
solvents [15], and hydrophobic [16]. Essential oils have antibacterial 
activity but low aqueous solubility [17]. Self-nanoemulsifying drug 
delivery system (SNEDDS) is one of the effective strategies to improve 
oral bioavailability [18], solubility [19] and it can control the drug release 
[20]. The purpose of the formula optimization study is to determine the 
variable level from which a strong product with high-quality 
characteristics can be produced [21]. 
The best formula to combine oils in water is needed to be generated. 
The present experiments were carried out in order to find the 
optimum formula of SNEDDS of Cymbopogon citratus essential oil 
followed by characterization. 
MATERIALS AND METHODS 
Preparation of SNEDDS  
Firstly, surfactant (Tween 80, Kao Indonesia Chemical, Bekasi, 
Indonesia), co-surfactant (PEG 400, idCHEM Co., Ltd., Kyunggi, South 
Korea), Cymbopogon citratus essential oil (Lansida Group, 
Yogyakarta, Indonesia) and virgin coconut oil/VCO (Healthy Co, 
Yogyakarta, Indonesia) were mixed using a magnetic stirrer (IKA® 
C-MAG HS 7, IKA WORKS Inc., Wilmington, NC, USA). Secondly, 
ultrasonicator (J. P Selecta, Barcelona, Spain) was utilized to make 
the SNEDDS formula uniformly disperse. Thirdly, SNEDDS formula 
was placed into a water bath (Memmert GmbH and Co. KG, 
Schwabach, Germany) at 45˚C for 15 min [22]. 
Percent transmittance 
SNEDDS formulations were added with a ratio of 1:50 with distilled 
water and mixed using vortex for 30 min. The percent transmittance 
was measured using UV-vis spectrophotometer (Genesys 10, 
Thermo Scientific Inc, Waltham, MA, USA) at 650 nm [21, 22]. 
Emulsification time 
The SNEDDS formula was added drop wise to 500 ml of artificial gastric 
fluid at 37˚C±2˚C. The artificial gastric fluid was composed of 
hydrochloric acid 37%, NaCl (Merck, Germany), and distilled water. 
Gentle agitation was provided by a magnetic stirrer (Stuart CB162 
Hotplate and Magnetic Stirrer, New Jersey, USA) rotating at 100 rpm. 
The assessment was conducted visually and the time for emulsification 
was taken [25]. 
Optimization of SNEDDS 
Along with the formula generated in our previous study [26], SNEDDS 
were optimized using a D-Optimal mixture experimental designed and 
performed using a Design Expert® Ver. 7.1.5. software (Stat-Ease Inc., 
Minneapolis, USA) [27] by selecting the percentage of the oil component 
X1 (a mixture of VCO and Cymbopogon citratus essential oil), the 
surfactant X2 (Tween 80), and the co-surfactant (PEG 400) as 
independent variables, while emulsification time in sec (Y1) and 
transmittance in percent (Y2) as responses. Data were analyzed by one-
way ANOVA at 0.05 levels [28]. 
Characterization of SNEDDS 
Measurement of droplet size and zeta potential 
The droplet size and zeta potential of the optimum formula were 
determined by dynamic light scattering techniques using a Zeta 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                               Vol 11, Issue 1, 2019 
Dono et al. 
Int J App Pharm, Vol 11, Issue 1, 2019, 144-149 
145 
potential/Particle-sizer (Horiba Scientific SZ-100, Horiba, Kyoto, 
Japan). Liquid SNEDDS (1 ml) was diluted to 100 ml with distilled 
water and performed in triplicate [29]. 
Viscosity 
The viscosity of optimum formula was measured by Brookfield 
viscometer (Brookfield engineering laboratories, Stoughton, MA, 
USA) at 25±0.5˚C, and at 12 rpm. The viscosity of each SNEDDS was 
performed in triplicate [30]. 
Thermodynamic stability study 
According to the method of [31], the study of the thermodynamic 
stability was implemented for optimum formula in three steps:  
1. Heating-cooling cycle: The optimum formula was stored at 4˚C 
and 45˚C for 48 h at each temperature using constant climate 
chamber bath, it was repeated for 6 cycles in triplicate. The 
formulation that withstands the heating-cooling cycle was continued 
to the centrifugation test. 
2. Centrifugation test: The optimum formula passed heating-
cooling cycle were centrifuged at 5000 rpm for 30 min, observed for 
any sign of creaming, cracking, or separation phase. 
3. Freeze-thaw cycle: The optimum formula passed centrifugation 
test were exposed at-21˚C and 21˚C for 24 h at each temperature, 
centrifuged at 3000 rpm 5 min, and continued visual observation. 
Transmission electron microscopy (TEM) 
The micro-morphology of the optimum formula was observed by 
TEM Joel JEM-100 CX (Joel, Tokyo, Japan). The SNEDDS was diluted 
with water (1:1000), a sample drop was stained with 2% 
phosphotungstic acid solution, and placed on a copper grid for 30 s 
[21].
 
Table 1: Level of the factors analyzed using D-optimal mixture experimental design 
Factors/Independent variables Level 
Low High 
X1 14.29 = Quantity of Oil (%) 20.00 
X2 60.00 = Quantity of Tween 80 (%) 71.43 
X3 14.29 = Quantity of PEG 400 (%) 20.00 
 
Table 2: Percentage of oil, tween 80, and PEG 400 and observed responses 
Run X X1 X2 Y3 Y1 2 
Oil (%) Tween 80 (%) PEG 400 (%) Transmittance (%) Emulsification time (s) 
1 17.737 67.973 14.290 99.600 53.480 
2 14.607 66.947 18.446 99.700 51.360 
3 14.293 71.417 14.290 99.900 42.430 
4 20.000 60.005 19.995 99.800 74.400 
5 20.000 60.005 19.995 99.100 85.170 
6 14.293 71.417 14.290 99.100 49.000 
7 16.764 66.028 17.208 99.800 42.890 
8 20.000 65.220 14.780 99.800 65.000 
9 17.493 62.507 20.000 99.600 70.940 
10 17.454 64.168 18.378 99.800 43.170 
11 14.986 65.014 20.000 99.600 48.030 
12 14.449 68.774 16.777 99.900 53.740 
13 14.986 65.014 20.000 99.500 49.330 
14 20.000 62.616 17.384 99.600 61.640 
15 17.737 67.973 14.290 99.800 55.640 
16 20.000 65.220 14.780 99.500 57.800 
The optimum formula was replicated three times and verified with a single sample t-test with OpenStat® (Industrial Technology Department, Iowa 
State University, USA). The optimum formula was selected for characterization. 
 
RESULTS AND DISCUSSION 
Optimization Formula of SNEDDS 
 
Table 3: The statistical parameter of each response using an experimental design 
Response F value Probability>F Significance 
Y = Emulsification time    
Model 9.32 0.0031 Significant 
Lack of fit 4.66 0.0535 Not significant 
Y = Transmittance    
Model 0.15 0.8596 Not significant 
Lack of fit 0.24 0.9652 Not significant 
 
Emulsification time 
The probability of the model was less than 0.05, and the lack of fit 
was more than 0.05 (table 3). This result indicated that the chosen 
model can describe the relationship between the variables. Fig. 1 
showed that the residual is normally distributed around the line and 
nothing stands out. The relationship between variables was 
illustrated using a special model cubic (fig. 2). 
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Fig. 1: The normal probability plot residual of emulsification time 
 
 
Fig. 2: Special model cubic of emulsification time of the mixture study result 
 
Emulsification time used as a response is a way to determine the 
ability of surfactant and co-surfactant components to emulsify oil 
components [32]. Selection of the optimum formula based upon 
“trading off” from the minimization of emulsification time. 
Emulsification time is one of the important keys to estimating 
emulsification efficiency [33]. 
 
 
Fig. 3: The normal probability plot residual of transmittance 
 
Percent transmittance 
The probability of the model and the lack of fit were both more than 
0.05 (table 3). The data indicated the chosen model can describe the 
relationship between the variables. Fig. 3 showed that the residual 
was normally distributed around the line and no one stands out. The 
relationship between variables was illustrated using a special model 
cubic (fig. 4). 
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Fig. 4: Special model cubic of transmittance of the mixture study result 
 
The optimization formula aimed to find products that have high-quality 
characteristics that will be produced [34]. Transmittance must be 
maximized to produce good quality products. The transmittance value of 
all treatments is above 99 percent, indicating the efficiency of self-
nanoemulsion [35]. A good nanoemulsion has a transmittance value 
close to 100 percent that indicated a clear nanoemulsion [36]. 
 
 
Fig. 5: Desirability 
 
The optimized formula that selected was the one that have a 
desirability value of close to 1 [37]. Fig. 5 showed the desirability 
which used to predict the optimum formula. The first solution found 
through numerical optimization and desirability value was 0.861. 
The composition of optimum formula consists of an oil component 
(14.293%), Tween 80 (71.417%), and PEG 400 (14.290%). 
 
Table 4: Predicted value and actual data of the optimized SNEDDS 
Response Actual data±SD Predicted value P-value 
Emulsification time 42.98±1.33 41.384 0.172 
Transmittance 99.73±0.12 99.693 0.604 
*Actual data are mean±SD, n=3 [SD: Standard deviation], the actual data and predicted value are shown in table 4. The P-value of emulsification time 
and transmittance was higher than 0.05, that indicated no significant difference between actual data and the predicted value.  
 
Characterization of SNEDDS 
Table 5: Droplet size, PI, zeta potential, and viscosity of the optimum formulation 
Replication Droplet size (nm) Polydispersity index (PI) Zeta potential (mV) Viscosity (mPa. s) 
R1 13.2 0.219 -22.6 200 
R2 13.2 0.118 -20.0 200 
R3 13.1 0.179 -20.1 200 
mean±SD 13.17±0.06 0.17±0.05 -20.90±1.47 200±0 
* SD: Standard deviation, n=3 
Dono et al. 




The droplet size of nanoemulsion was found to be 13.17±0.06 with 
polydispersity-index (PI) 0.17±0.05 (table 5). Droplet size is a 
crucial factor to evaluate the system of nanoemulsion [38]. Smaller 
particle size causes better absorption at gastrointestinal tract [39]. 
The optimum formula shows a PI value lower than 0.5 which 
indicate uniformity droplet size distribution [40]. 
Zeta potential 
The zeta potential of the optimum formulation was -20.90±1.47 mV 
as shown in table 5. The fatty acid content in the formula may cause 
the negative charge of the zeta potential [41]. 
Viscosity measurement 
The viscosity of the optimum formulation is 200±0 mPa. 
Thermodynamic stability 
s (table 5). 
The concentration of surfactant and carrier oil used in SNEDDS is 
related to the value of viscosity [18]. The viscosity is directly 
proportional to the oil concentration [42]. 
The optimum SNEDDS formula did not change visible appearance which 
showed good stability at various storage conditions (table 6). 
Nanoemulsion is more stable than an emulsion, SNEDDS that will form 
nanoemulsion must be thermodynamically stable with the characteristic 
of not experiencing precipitation, cracking, or creaming [43]. 
 
Table 6: Results for thermodynamic stability studies 
Replication Heating-cooling cycle Centrifugation test Freeze-thaw cycle 
R1 √ √ √ 
R2 √ √ √ 
R3 √ √ √ 
 
 
Fig. 6: TEM of optimized SNEDDS formulation (80,000×; dilution 
1000-fold with water) 
 
Transmission electron microscopy (TEM) 
The TEM of the optimum formula is presented in fig. 6. After 
dilution, all droplets demonstrated spherical shape and almost same 
size, represented a successful formation of SNEDDS. The TEM of the 
optimized formulation shows no coalescence signs indicating that 
the selected formula has good quality [44]. 
CONCLUSION 
The optimization of Cymbopogon citratus SNEDDS using D-Optimal 
mixture experimental design was performed. The optimum formula 
for SNEDDS was a mixture of Tween 80, PEG 400, VCO, and 
Cymbopogon citratus essential oil at a ratio of 71.417: 14.290: 7.147: 
7.147 (%). From the optimizing formula can be shown that the mean 
of droplet size, PI, zeta potential, and viscosity were: 13.17±0.06 nm, 
0.17±0.05,-20.90±1.47 mV, 200±0 mPa. 
ACKNOWLEDGMENT 
s, respectively. Furthermore, 
the optimized formula was passed the thermodynamic stability test, 
meanwhile team displayed spherical shape. The optimized SNEDDS 
formula was improving solubility of poorly soluble Cymbopogon 
citratus essential oil. 
The authors are thankful to Biopharmaceutics Laboratory, 
Department of Pharmaceutics, Faculty of Pharmacy, Universitas 
Gadjah Mada Yogyakarta for an availing facility for these 
optimization studies. The author expresses gratitude towards DIKTI 
Ministry of Research, Technology, and Higher Education Indonesia 
for funding the project under the scheme of PMDSU No. 2050/ 
UN1/DITLIT/DIT-LIT/lT/2018. 
AUTHOR CONTRIBUTIONS 
All the authors have contributed equally 
CONFLICT OF INTERESTS 
All the authors declared none 
REFERENCES 
1. Sugiharto S. Role of nutraceuticals in gut health and growth 
performance of poultry. J Saudi Soc Agric Sci 2016;15:99-111. 
2. Patterson JA, Burkholder KM. Application of probiotics and 
probiotics in poultry production. Poult Sci 2003;82:627-31. 
3. Amit Romach E, Sklan D, Uni Z. Microflora ecology of the 
chicken intestine using 168 ribosomal DNA primers. Poult Sci 
2004;83:1093-8. 
4. Krocko M, Canigova M, Bezekova J, Lavova M, Hascik, Duckova 
J. Effect of nutrition with propolis and bee pollen supplements 
on bacteria colonization pattern in the gastrointestinal tract of 
broiler chickens. Sci Pap Anim Sci Biotechnol 2012;45:63-7. 
5. La Ragione RM, Narbad, Gasson MJ, Woodward MJ. In vivo 
characterization of Lactobacillus johnsonii F19785 for use as a 
defined competitive exclusion agent against bacterial 
pathogens in poultry. Lett Appl Microbiol 2004;38:197-205. 
6. Hajati H, Rezaei M. The application of prebiotics in poultry 
production. Int J Poult Sci 2010;9:298-304. 
7. Si W, Gong J, Tsao R, Zhou T, Yu H, Poppe C, et al. Antimicrobial 
activity of essential oils and structurally related synthetic food 
additives towards selected pathogenic and beneficial gut 
bacteria. J Appl Microbiol 2006;100;296-305. 
8. Grashorn MA. Use of phytobiotics in broiler nutrition–an 
alternative to infeed antibiotics? J Anim Feed Sci 2010;19:338-
47.  
9. Oussalah M, Caillet S, Saucier L, Lacroix M. Inhibitory effects of 
selected plant essential oils on the growth of four pathogenic 
bacteria: E coli O157:H7, Salmonella typhimurium, 
Staphylococcus aureus, and Listeria monocytogenes. Food 
Control 2007;18:414-20. 
10. Singh RK, Ebibeni N. Antimicrobial activity of lemongrass 
(Cymbopogon citratus) oil against microbes of environmental, 
clinical and food origin. Int Res J Pharm Pharmacol 2011;1:228-36. 
Dono et al. 
Int J App Pharm, Vol 11, Issue 1, 2019, 144-149 
149 
11. Asaolu MF, Oyeyemi OA, Olanloku JO. Chemical compositions, 
phytochemical constituents and in vitro biological activity of 
various extracts of Cymbopogon citratus. Pak J Nutr 
2009;8:1920-2. 
12. Fagbemi JF, Ugoji E, Adenipekun T, Adelowotan O. Evaluation 
of the antimicrobial properties of unripe banana (Musa 
sapientum L.), lemongrass (Cymbopogon citratus S.) and 
turmeric (Curcuma longa L.) on pathogens. Afr J Biotechnol 
2009;8:1176-82. 
13. Naik MI, Fomda BA, Jaykumar E, Bhat JA. Antibacterial activity 
of lemongrass (Cymbopogon citratus) oil against some selected 
pathogenic bacterias. Asian Pac J Trop Med 2010;3:535-8. 
14. Juniatik M, Hidayati K, Wulandari FP, Pangestuti N, Munawaroh 
N, Martien R, et al. Formulation of nanoemulsion mouthwash 
combination of lemongrass oil (Cymbopogon citratus) and 
kaffir lime oil (Citrus hystrix) against Candida albicans ATCC 
10231. Trad Med J 2017;22:7-15. 
15. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological 
effects of essential oils-a review. Food Chem Toxicol 
2008;46:446-75. 
16. Sanchez Gonzalez L, Vargaz M, Gonzalez Matinez C, Chiralt A, 
Chafer M. Use of essential oils bioactive edible coatings: a 
review. Food Eng Rev 2011;3:1-16. 
17. Khumpirapang N, Pikulkaew S, Mūllertz A, Rades T, Okonogi S. 
Self-micro emulsifying drug delivery system and nanoemulsion 
for enhancing aqueous miscibility of Alpinia galanga oil. PLoS 
One 2017;12:1-18. 
18. Saritha D, Bose PSC, Nagaraju R. Formulation and evaluation of 
self-emulsifying drug delivery system (SEEDS) of ibuprofen. Int 
J Pharm Sci Res 2014;5:3511-9. 
19. Bansal M, Jamil S. Micellar microparticles: a novel approach to 
tropical drug delivery system. Int J Appl Pharm 2018;10:1-5. 
20. Baskar V, Salim MI, Subramani A, Sruthi, Jawahar A, Shabeer 
TK. Historic review on the modern herbal nanogel formulation 
and delivery methods. Int J Pharm Pharm Sci 2018;10:1-10. 
21. Basalious EB, Shawky N, Badr Eldin SM. SNEDDS containing 
bioenhancers for improvement of dissolution and oral 
absorption of lacidipine. I: development and optimization. Int J 
Pharm 2010;391:203-11. 
22. Lalwani JT, Thakkar VT, Patel HV. Enhancement of solubility 
and oral bioavailability of ezetimibe by a novel solid self nano 
emulsifying drug delivery system (SNEDDS). Int J Pharm Pharm 
Sci 2013;5:513-22. 
23. Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Self-
nanoemulsifying drug delivery system (SNEDDS) of the poorly 
water-soluble grapefruit flavonoid naringenin: design, 
characterization, in vitro and in vivo evaluation. Drug Delivery 
2015;22:552-61. 
24. Winarti L, Suwaldi, Martien R, Hakim L. Formulation of self-
nanoemulsifying drug delivery system of bovine serum 
albumin using HLB (hidrophilic-lypophilic balance) approach. 
Indonesian J Pharm 2016;27:117-27. 
25. Parmar N, Singla N, Amin S, Kohli K. Study of cosurfactant effect 
on nanoemulsifying area and development of lercadipine 
loaded (SNEDDS) self nanoemulsifying drug delivery system. 
Colloids Surf B 2011;86:327-38. 
26. Ujilestari T, Dono ND, Ariyadi B, Martien R, Zuprizal. 
Formulation and characterization of self-nano emulsifying drug 
delivery systems of lemongrass (Cymbopogon citratus) 
essential oil. Malays J Fund Appl Sci 2018;14:360-3. 
27. Wani A, Sanghani C, Wani S. Formulation, characterization, and 
in vitro evaluation of novel microemulsion-based spray for 
topical delivery of isotretinoin. Asian J Pharm Clin Res 
2018;11:226-32. 
28. Shinkar DM, Aher PS, Kothawade PD, Maru AD. Formulation 
and in vitro evaluation of fast dissolving tablet of verapamil 
hydrochloride. Int J Pharm Pharm Sci 2018;10:93-9. 
29. Dash RN, Mohammed H, Humaira T, Reddy AV. Solid 
supersaturatable self-nanoemulsifying drug delivery systems 
for improved dissolution, absorption and pharmacodynamic 
effects of glipizide. J Drug Delivery Sci Technol 2015;28:28-36. 
30. Ghosh PK, Majithiya RJ, Umrethia ML, Murthy SR. Design and 
development of microemulsion drug delivery system of 
aclyclovir for improvement of oral bioavailability. AAPS 
PharmSciTech 2006;7:172-7. 
31. Kaur G, Chandel P, Harikumar SL. Formulation of self 
nanoemulsifying drug delivery system (SNEDDS) of celecoxib 
for improvement of oral bioavailability. Pharmacophore 
2013;4:120-33. 
32. Patel HK, Patel PV, Misan CK, Mehta DS, Patel MB. Development 
and characterization of liquid and solid self-microemulsifying drug 
delivery system of tacrolimus. Asian J Pharm 2012;6:204-11. 
33. Sahoo SK, Suresh P, Acharya U. Design and development of self-
microemulsifying drug devilery systems (SMEDDS) of 
telmisartan for enhancement of in vitro dissolution and oral 
bioavailability in rabbit. Int J Appl Pharm 2018;10:117-26. 
34. Holm R, Jensen IHM. Optimization of self-microemulsifying drug 
delivery systems (SMEDDS) using a D-optimal design and the 
desirability function. Drug Dev Ind Pharm 2006;32:1025-32. 
35. Gambhire RS, Gujar KN, Gambhire VM. Design and evaluation of 
self-nanoemulsifying drug delivery systems for nebivolol 
hydrochloride. Asian J Pharm 2014;8:200-9. 
36. Madan JR, Sudarshan B, Kadam VS, Kamal D. Formulation and 
development of self-microemulsifying drug delivery system of 
pioglitazone hydrochloride. Asian J Pharm 2014;8:27-35. 
37. Beg S, Swain S, Singh HP, Patra CN, Rao MEB. Development, 
optimization, and characterization of solid self-
nanoemulsifying drug delivery systems of valsartan using 
porous carriers. AAPS PharmSciTech 2012;13:1416-27. 
38. Jeevana JB, Sreelakhmi K. Design, and evaluation of self-
nanoemulsifying drug delivery system of flutamide. J Young 
Pharm 2011;3:4-8. 
39. Subramanian P, Siddalingam R. Self-nanoemulsifying drug delivery 
systems of poorly soluble drug dutasteride: formulation and in 
vitro characterization. J Appl Pharm Sci 2017;7:11-2. 
40. Chavda H, Patel J, Chavada G, Dave S, Patel A, Patel C. Self-
nanoemulifying powder of isotretinoin: Preparation and 
characterization. J Powder Technol 2013;1-9. 
http://dx.doi.org/10.1155/2013/108569 
41. Bandivadekar M, Pancholi S, Kaul-ghanekar R, Choudhari A, 
Koppikar S. Single non-ionic surfactant based self-
nanoemulsifying drug delivery systems: formulation, 
characterization, cytotoxicity and permeability enhancement 
study. Drug Dev Ind Pharm 2013;39:696-703. 
42. Rahman MA, Iqbal Z, Hussain A. Formulation optimization and 
in vitro characterization of sertraline loaded self-
nanoemulsifying drug delivery system (SNEDDS) for oral 
administration. J Pharm Invest 2012;42:191-202. 
43. Kassem AA, Mohsen AM, Ahmed RS, Essam TM. Self-
nanoemulsifying drug delivery system (SNEDDS) with 
enhanced solubilization of nystatin for treatment of oral 
candidiasis: design, optimization, in vitro and in vivo evaluation. 
J Mol Liq 2016;218:219-32. 
44. Bahloul B, Lassoued MA, Seguin J, Lai-Kuen R, Dhotel H, Sfar S, 
Mignet N. Self-nanoemulsifying drug delivery system 
developed by the HLB-RSM approach: characterization by 
transmission electron microscopy and pharmacokinetic study. 
Int J Pharm 2015;487:56-63. 
 
